Patrick Y. Wen

Epidemiology of Brain Metastases

P. Wen, E. Lee, Lakshmi Nayak, 2012, Current Oncology Reports.

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Thomas Benner, Percy Ivy, Marek Ancukiewicz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

Albert Lai, Soonmee Cha, Rajan Jain, 2012, Journal of Neuro-Oncology.

Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression

P. Wen, A. Norden, E. Gerstner, 2009, Journal of Neuro-Oncology.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

Susan Chang, Frank Lieberman, Susan M. Chang, 2011, Journal of Neuro-Oncology.